Reigning World Marathon Champion Peres Jepchirchir Provisionally Suspended Over Positive EPO Test

The Athletics Integrity Unit has provisionally suspended reigning world marathon champion Peres Jepchirchir after an out-of-competition test detected the presence of recombinant erythropoietin, commonly known as EPO. The adverse analytical finding emerged from a screening conducted in Kenya prior to her recent victory at the Sydney Marathon. The decision temporarily bars the decorated runner from all sanctioned competitions while formal proceedings take place.

EPO is a synthetic hormone strictly prohibited under the World Anti-Doping Code due to its ability to stimulate red blood cell production, boosting oxygen delivery and aerobic endurance. Anti-doping officials confirmed that Jepchirchir was notified of the result in accordance with standard international testing protocols. The provisional sanction took effect immediately upon the formal notification of the test outcome.

Jepchirchir, 33, stands among the most accomplished road racers of modern track and field. Her landmark achievement came at the Tokyo 2020 Olympic Games, where she secured the women's marathon gold medal in gruelling summer conditions. She subsequently reinforced her status at the pinnacle of distance running by capturing the world marathon title in Tokyo during the 2025 World Championships.

Beyond global championships, Jepchirchir established an extraordinary record across the World Marathon Majors circuit. Her resume includes high-profile victories at the New York City Marathon in 2021, the Boston Marathon in 2022, and the London Marathon in 2024. Her dominant performance in Sydney had further cemented her position as a defining figure of her running generation.

The announcement represents one of the most prominent doping investigations involving an active Olympic and world champion in road racing. Over recent years, international anti-doping authorities have intensified testing regimens and targeted intelligence operations across elite distance training hubs. Jepchirchir's provisional suspension lands amid heightened scrutiny regarding compliance and biological profiling across the international marathon landscape.

Under the rules governing the Athletics Integrity Unit, a provisional suspension does not constitute a final determination of guilt. Athletes subject to an adverse analytical finding retain the right to request the testing of their reserve B-sample to confirm or challenge the initial laboratory report. Jepchirchir also has the opportunity to present medical explanations or challenge the findings before an independent tribunal.

If the violation is substantiated, Jepchirchir could face a standard multi-year period of ineligibility under global anti-doping guidelines, typically ranging up to four years for non-specified substances like EPO. A confirmed ruling would also result in the retroactive disqualification of results earned following the collection date of the positive sample, including potential loss of prize money and titles.

The development delivers a significant reputational blow to international road running as organisers and federations seek to bolster trust in championship performances. Sports integrity advocates have consistently stressed that vigorous out-of-competition screening remains essential to safeguarding fair play, regardless of an athlete's profile or previous accolades. The case underscores the rigorous threshold required to police elite international distance competitions.

The case will now proceed through the formal disciplinary timeline established by World Athletics and the AIU. Officials will review any defense submissions, laboratory documentation, and procedural arguments before issuing a final verdict or referring the matter to an independent hearing. For now, the sporting world awaits the formal resolution of one of distance running's most consequential integrity cases.